For pharma patient services leaders and patient-facing teams navigating the shift to direct-to-patient. Practical insights from two operators who have lived it.
Pharma patient services leaders are facing a revolutionary change. Patients have access to more information than ever, therapies are growing more complex, and the industry is shifting direct to patient. A patient confusion crisis is emerging, and most organizations are not ready.
Each episode delivers practical insights leaders can use and reps can apply in the field to better educate patients, build trust, and drive better outcomes. No fluff. Just real experience from two operators who have been in the room.
As pharma goes direct to patient and therapies grow more complex, patients are overwhelmed, misinformed, and walking away. The consequences land directly on your commercial outcomes.
Patients leave the pharmacy without filling. Confusion about cost, complexity, or side effects goes unaddressed.
Patients who start therapy stop. Without ongoing education and support, complex regimens are abandoned early.
Patients are turning to social media for answers. What they find often contradicts their physician's guidance.
Learn how leading organizations are redesigning patient services programs to reduce abandonment and improve time-to-therapy as therapies grow more complex.
Understand how the D2P shift is changing what commercial success looks like and what your patient-facing teams need to win in the field.
Get practical perspective on how patient confusion around cost and coverage is eroding access gains and what education strategies are closing the gap.
Walk away with language, frameworks, and tools you can use in the next patient or HCP conversation to reduce hesitation and improve follow-through.
Explore how scientific communication is failing at the patient level and what physician-led education strategies are actually moving adherence metrics.
Discover how the most successful launches are building patient confidence before the prescription is written, not after patients abandon at the pharmacy.
"There is an emerging patient confusion crisis as pharma goes direct to patient. And most organizations are not ready for it."
Former Pfizer leader across Sales and Marketing, Medical Affairs, Patient Access, and Patient Engagement with 23 years of experience. Now CEO of Hoot, Bob brings an operator's perspective on what it actually takes to reach and retain patients in a complex therapy landscape.
Follow Bob on LinkedIn
25 years of c-Suite experience across pharma commercial operations, patient services, and marketing. Jason has built and led patient-facing organizations through major therapy launches and helped define what best-in-class patient services looks like in the modern era.
Follow Jason on LinkedInEvery episode starts as a live conversation on Bob Miglani's LinkedIn. Join in real time, ask questions, and be part of the discussion as it happens. After each session, the full episode is published across all major podcast platforms for your team to share and revisit.
Here is how to catch each live session as it happens:
Bob Miglani and Jason Grossman explore how Pharma’s shift to Direct to Patient is fueling a patient confusion crisis and why clearer, HCP-led education is becoming essential.
This episode explores how the increasingly complex patient journey is fueling a growing patient confusion crisis and why clearer, more guided education is critical in a Direct to Patient world.
This episode features innovation leader Dan Seewald discussing how AI is reshaping pharma marketing, patient education, and trust, and why it demands more personalized, clearer guidance in a Direct to Patient world.
Bob and Jason are always looking for pharma patient services leaders, patient engagement innovators, and commercial operators with a point of view. If you have experience in patient education, therapy adherence, hub operations, or the D2P shift, we want to hear from you.
Share your expertise with thousands of pharma patient services leaders, commercial teams, and field reps actively looking for guidance.
